JPRN-UMIN000008224已完成未知
Safety and efficay of a Coleus forskohlii formulation - Dose escalation of a Coleus forskohlii formulation
DHC Corporation0 个研究点目标入组 30 人开始时间: 2012年6月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •- Subjects who have an inappropriate clinical history for efficacy and safety assessment in the study (such as drug abuse, alcoholism, and the disease of heart, liver, kidney, lungs, eye, blood etc) and who is taking any drugs. - Subjects judged to be inappropriate for the study by the investigator.
研究者
相似试验
已完成
不适用
Safety of a Coleus forskohlii formulatioobesityJPRN-UMIN000021655DHC Corporation29
已完成
2 期
Effect Of Coleus Forskohlii On ObesityCTRI/2022/06/043221Star Hi Herbs PvtLtd60
尚未招募
2 期
Clinical verification of homoeopathic medicine Coleus forskohliiCTRI/2023/11/059582Central Council for Research in Homoeopathy
已完成
不适用
A CLINICAL STUDY OF RAW CFE(COLEUS FORSKOHLII EXTRACT)AS A FOOD SUPPLEMENT FOR THE ASSESSMENT OF ASSOCIATED HEALTH BENEFITS FOR HEALTHY HUMAN SUBJECTS.CTRI/2016/06/007023PIONEER EXTRACTS PVT LTD
招募中
2 期
management of microalbuminuria in type 2 diabetesCTRI/2016/07/007075KLEU BMK AYURVEDA MAHAVIDYALAYA10